These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 20731018)
1. High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K. Treekitkarnmongkol W; Suthiphongchai T World J Gastroenterol; 2010 Aug; 16(32):4047-54. PubMed ID: 20731018 [TBL] [Abstract][Full Text] [Related]
2. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540 [TBL] [Abstract][Full Text] [Related]
3. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827 [TBL] [Abstract][Full Text] [Related]
4. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. Menakongka A; Suthiphongchai T World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
7. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601 [TBL] [Abstract][Full Text] [Related]
9. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131 [TBL] [Abstract][Full Text] [Related]
10. Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Obchoei S; Detarya M; Boonnate P; Saranaruk P; Vaeteewoottacharn K; Mahalapbutr P; Okada S; Wongkham S Asian Pac J Cancer Prev; 2022 Oct; 23(10):3379-3386. PubMed ID: 36308362 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell. Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696 [TBL] [Abstract][Full Text] [Related]
12. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells. Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364 [TBL] [Abstract][Full Text] [Related]
13. Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells. Pongcharoen P; Jinawath A; Tohtong R Clin Exp Metastasis; 2011 Dec; 28(8):827-39. PubMed ID: 21833756 [TBL] [Abstract][Full Text] [Related]
15. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion. Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681 [TBL] [Abstract][Full Text] [Related]
16. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521 [TBL] [Abstract][Full Text] [Related]
17. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling. Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855 [TBL] [Abstract][Full Text] [Related]
18. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma. Tan XY; Chang S; Liu W; Tang HH Gut Liver; 2014 Mar; 8(2):196-204. PubMed ID: 24672662 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings. Sriraksa R; Limpaiboon T Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164 [TBL] [Abstract][Full Text] [Related]
20. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT. Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]